RGF
GALT icon

Retirement Guys Formula’s Galectin Therapeutics GALT Stock Holding History

Retirement Guys Formula’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$979K Buy
211,053
+23,991
+13% +$62.2K 0.37% 94
2026
Q1 		$522K Buy
187,062
+2,500
+1% +$7.61K 0.24% 95
2025
Q4 		$768K Buy
184,562
+18,569
+11% +$97.8K 0.35% 99
2025
Q3 		$703K Buy
165,993
+6,400
+4% +$24.1K 0.25% 107
2025
Q2 		$337K Buy
159,593
+4,250
+3% +$6.36K 0.13% 110
2025
Q1 		$190K Hold
155,343
– – 0.09% 137
2024
Q4 		$200K Buy
155,343
+91,526
+143% +$219K 0.1% 135
2024
Q3 		$175K Buy
63,817
+22,660
+55% +$55.6K 0.08% 128
2024
Q2 		$93K Buy
41,157
+7,425
+22% +$22.6K 0.04% 124
2024
Q1 		$80.6K Buy
33,732
+12,232
+57% +$23.1K 0.04% 121
2023
Q4 		$35.7K Buy
21,500
+10,000
+87% +$19.4K 0.02% 125
2023
Q3 		$22.1K Buy
+11,500
New +$18.9K 0.02% 120

Other funds holding GALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Retirement Guys Formula's GALT Position: Q2 2026 in Review

Retirement Guys Formula increased its Galectin Therapeutics (GALT) stake by 13% in Q2 2026, buying an estimated $62.2K and bringing the position to 211,053 shares worth $979K. The position accounts for 0.37% of the portfolio, ranked #94.

Retirement Guys Formula first reported a position in GALT in Q3 2023 and has held it in 12 quarters since. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

  • Retirement Guys Formula held 211,053 shares of Galectin Therapeutics worth $979K as of Q2 2026.
  • Retirement Guys Formula bought 23,991 Galectin Therapeutics shares in Q2 2026, an estimated $62.2K.
  • Galectin Therapeutics made up 0.37% of Retirement Guys Formula's portfolio in Q2 2026, its #94 holding.
  • Retirement Guys Formula first reported a position in Galectin Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on Retirement Guys Formula's 13F filing for Q2 2026, filed 30 Jul 2026.